Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Retina > Tele-Education Programs Needed for ROP Management
  • Retina

Tele-Education Programs Needed for ROP Management

Ophthalmology 360
Tele-Education Programs Needed for ROP Management

Tele-education programs for ophthalmology are becoming more popular and needed. There is an even greater need for it to help patients manage retinopathy of prematurity (ROP). Barriers to providing ROP care include medicolegal liability, reimbursement, and complex coordination of care. Improving ROP education is important because ophthalmologists may be the only providers screening for ROP.

Currently, there is no standard for ROP training at the residency or fellowship level in the US. Tele-education platforms provide an opportunity for standardization of assessment.

An international survey of ophthalmologists reported that only 1% to 33% of ROP screenings were performed under direct attending supervision. A web-based study that assessed classification of ROP based on widefield retinal images found that ROP was correctly diagnosed by international ophthalmology residents in less than half of cases, and treatment-requiring ROP and type 2 ROP were commonly underdiagnosed. There was no difference between trainees in higher and lower income countries.

Tele-education programs could improve access to ROP education and ensure adequate training. Some are currently available in the US, Mexico, Mongolia, Brazil, the Philippines, and several other countries. They’ve also been shown to improve ophthalmology trainees’ competency in diagnosing zone, stage, and presence or absence of plus disease.

In Mexico, trainees who completed a tele-education program had 94% specificity for diagnosing AP-ROP, 92% specificity for diagnosing type 2 or worse ROP, and 89% specificity for treatment-requiring ROP. In the US, they demonstrated improvement in sensitivity noted for AP-ROP and diagnosing plus disease.

Current tele-education offerings exist within telemedicine systems, including iTelegen and FocusROP/Phoenix CONNECT. Future goals include developing platforms capable of being tailored to specific users and types of learners.

You can read more here.

Share

Related Content

  • Retina

Biosimilar aflibercept-ayyh demonstrates favorable real-world safety and efficacy

  • Retina

Switching to aflibercept 8 mg improved anatomical outcomes in previously treated nAMD

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency
  • Retina

Treat-and-extend aflibercept 8 mg improves outcomes in nAMD over 1 year

  • Retina

Intravitreal therapy in nAMD linked to lower depression and anxiety risk

  • Retina

Alternative aflibercept regimens maintained efficacy in wet AMD

  • Retina

Nanoscope Therapeutics is working on the potential first-ever optogenetic therapy for retinal diseases

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon